We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
504 hedge funds and large institutions have $29B invested in Alexion Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 179 increasing their positions, 203 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
179% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 28
15% more capital invested
Capital invested by funds: $25.3B → $29B (+$3.69B)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
9% more funds holding
Funds holding: 462 → 504 (+42)
3% less call options, than puts
Call options by funds: $194M | Put options by funds: $200M
12% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 203
Holders
504
Holders Change
+42
Holders Change %
+9.09%
% of All Funds
14.56%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.26%
New
78
Increased
179
Reduced
203
Closed
28
Calls
$194M
Puts
$200M
Net Calls
-$5.93M
Net Calls Change
-$138M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$191M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$177M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$156M |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$116M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$97.3M |
